Pharmaceutical Industry Research Articles

Retail Marketing Strategies in the Pharmaceutical Industry and its Approach for Chronic Diseases

The pharmaceutical industry plays a vital role in the healthcare sector, particularly in medication development and distribution to deal with many chronic diseases. Since chronic diseases like diabetes, cardiovascular disorders, and respiratory diseases keep increasing around the globe, there is a huge need for effective pharmaceutical retail marketing, not only creating awareness but also creating access to essential medicinal drugs for the patient. Chronic conditions are quite different from acute conditions, mainly because the disease process is more continuous than discontinuous. Much more extended relationships with the healthcare providers are needed for chronic conditions, and equally, extended relationships with patients are needed to ensure continued management of diseases. In retail marketing strategy, therefore, acquiring appropriate consciousness among patients about their treatment choices, ensuring easy access to the drugs, and following the course of treatment prescribed are thus crucial.

Enhancing the selective catalytic oxidation of lignocellulosic biomass to formic acid using hydrogen peroxide and a reusable MgAl hydrotalcite-derived as a catalyst in a green solvent

Biofuels or liquid fuels derived from natural matter, are one of the most intriguing yet divisive alternatives for petroleum-based fuels. The most common approach to produce biofuels is to transform plant sugars and other carbohydrates into oxygen-deficient chemicals. A growing relevance has been devoted in the direct synthesis of platform molecules from biomass resources, using one-pot or cascade techniques via adequate catalytic system tuning and improvement of the reaction conditions which have merged as a beneficial strategy from an economic and ecological standpoint. In a similar vein, the major objective of this contribution was to investigate and enhance the conditions for a selective oxidation of lignocellulosic biomass-derived cellulose to yield formic acid (FA), the latter is one of the most coveted liquid hydrogen carriers and among the key compounds used in the pharmaceutical, cosmetic, and leather industries. Both oxidizing aqueous hydrogen peroxide and calcined heterogeneous hydrotalcite catalyst have been employed at an atmospheric pressure for this purpose. The effect of reaction time, temperature, amount of catalyst and oxidant on the product's yield and selectivity have been investigated. The oxidation of a plant-derived cellulosic fiber at 70 °C using an H2O2 excess (7 mmol) provided an impressive result with a high yield and TON of 61.0 %, 12.30 respectively, the latter was confirmed to be relatively close to the one from the oxidation of pure cellulose. Furthermore, the reusability of the catalyst has also been studied which was demonstrated to result in the same yields for one reuse and 3 recycles.

Tomato Waste as a Sustainable Source of Antioxidants and Pectins: Processing, Pretreatment and Extraction Challenges

Tomato processing waste (TPW), a byproduct of the tomato processing industry, is generated in significant quantities globally, presenting a challenge for sustainable waste management. While traditionally used as animal feed or fertilizer, TPW is increasingly recognized for its potential as a valuable raw material due to its high content of bioactive compounds, such as carotenoids, polyphenols and pectin. These compounds have significant health benefits and are in growing demand in the pharmaceutical and cosmetic industries. Despite this potential, the broader industrial utilization of TPW remains limited. This review explores the influence of various processing, pretreatment and extraction methods on the concentration and stability of the bioactive compounds found in TPW. By analyzing the effects of these methodologies, we provide insights into optimizing processes for maximum recovery and sustainable utilization of TPW. Additionally, we address the major challenges in scaling up these processes for industrial application, including the assessment of their ecological footprint through life cycle analysis (LCA). This comprehensive approach aims to bridge the gap between scientific research and industrial implementation, facilitating the valorization of TPW in line with circular economy principles.

First Report on Salvia Sahendica Boiss & Buhs roots biocomponents characterization by GC-MS and HPLC and Antibacterial Potency

Treatment of bacterial infections with antibiotic resistance is complicated. For this reason, new therapeutic methods are needed to control bacterial infections. Therefore, it is necessary to discover new antibiotics from medicinal plants that can destroy drug-resistant bacteria. Essential oils (EO) of some medicinal plants have antimicrobial effects and can be used as antimicrobial agents in the treatment of infections and food industries. The aim of this study was to determine the EO composition and antimicrobial effects of EO and polyphenols profile of Salvia Sahendica roots for the first time. Chemical compounds and antibacterial activity of EOs against Staphylococcus aureus and Bacillus cereus as gram-positive and Escherichia coli and Pseudomonas aeruginosa as gram- negative bacteria were evaluated using microtiter broth dilution method. Studied organs of S. sahendica showed significant diversity in terms of type and percentage of essential oil and polyphenol compounds. Overall, 44, 46, 42, and 45 compounds were identified in the essential oil of leaves, flowers, stems, and roots of this plant, which constituted 99.6, 99.3, 98.2, and 99.4% of total oil composition, respectively. The current study collectively demonstrated inhibitory effects ranged from strong (S. aureus) to low inhibition (P. aeruginosa). According to the HPLC result, the amounts of coumaric acid, chlorogenic acid, and gallic acid compounds in the root are higher than in other plant parts, which indicate that the root can be a suitable source for the production of these valuable polyphenol compounds. Due to the results, it is possible to hope for the application of EO from S. sahendica as natural antibacterial in the pharmaceutical and food industries.

Navigating investigator-initiated clinical trials: A call for guidelines & monitoring frameworks from an Indian context

Investigator-initiated clinical trials – also known as non-regulatory or academic clinical trials, are conducted by investigators from academia or research organizations. They usually aim to address scientific questions with insufficient commercial implications and generate real-world applicable solutions, unlike trials sponsored by the pharmaceutical industry which are primarily focused on marketing approval of products that have a commercial value. For the trial results to be credible, adhering to robust methodology and the highest quality standards is paramount. Currently, investigator-initiated clinical trials in India are beyond the purview of the national regulatory authority. They are guided mainly by the National Ethical Guidelines for Biomedical and Health Research Involving Human Participants, 2017 published by Indian Council of Medical Research. They lack an accepted framework for review, conduct, monitoring, reporting of adverse events, and participant compensation. Considering this scenario, we discuss the challenges faced in an investigator initiated clinical trial and explore plausible solutions.

Utilization of IoT and database system of central warehouse project in the pharmaceutical industry

This study aims to develop an MRPII device that utilizes internet technology for inventory management control processes, using case studies from pharmacutical companies in Indonesia. The research was conducted using field observation methods and system development, then comparing the manual system and MRPII. An internet-based inventory management system was created by integrating the warehouse’s material database into each material code via a QR. code. The study found that implementing the MRP II system design increases work effectiveness and reduces the risk of errors that frequently occur in conventional systems. Moreover, using the MRPII can facilitate the audit process and establish transparency in the inventory management process. Data processed using IoT is generated faster and more accurately as company operations improve quality, reduce unnecessary activities, and make it easier to organize materials and run administrative and technical processes in inventory management; it is measured based on reach, workforce requirements, supply, and handling time. In the industrial world, the MRPII database system has the potential to evolve into several more complex and comprehensive systems. It has broad integration and can assist humans working across all lines, particularly in the data processing system.

Characterization of Beer Produced with the Addition of Brown Macroalgae Fucus virsoides

Marine macroalgae are organisms rich in bioactive compounds such as polysaccharides, polyphenols, and various minerals. Macroalgae are increasingly being added to the human diet precisely because they contain useful compounds that can also be used in the pharmaceutical industry. Previous research describes their addition to meat products, yogurt, bread, and baby food. However, data on the addition of algae to beer have been scarce. The goal of this work was to produce beer with the addition of brown macroalgae (Fucus virsoides) from the Adriatic Sea. In addition, the basic physical–chemical parameters (color, pH, ethanol, extract, and polyphenols) were determined. The most important premise is the transfer of selenium (Se) to beer, since Se is deficient in human food chain. The transfer of different metals, namely, S (sulfur), Mg (magnesium), P (phosphorus), K (potassium), Ca (calcium), Cr (chromium), Mn (manganese), Fe (iron), Co (cobalt), Ni (nickel), Cu (copper), Zn (zinc), As (arsenic), Se (selenium), Mo (molybdenum), Cd (cadmium), Hg (mercury), and Pb (lead), from algae to beer was determined using inductively coupled plasma–mass spectrometry (ICP−MS). The results, however, were not satisfactory regarding metal transfer. In particular, Se was detected in beer, but other metals such as As, Cd, and Pb were not. Alga addition contributed to extract values, and the original extract reached 14.3 °P in wort with alga addition, as opposed to 12.8 °P in the control sample. Such high extract content, however, resulted in beer with low alcohol content, <4% v/v for both beers. This could be explained by the high levels of unfermentable extract. pH values showed statistical difference between samples, meaning that the addition of algae significantly affected the pH value of beer, reducing acidity by almost 5%.

Chromatography and Spectroscopic Technique-Based Rapid Characterization of Nano-Carrier Pharmaceuticals.

A nanocarrier is a novel colloidal system whose particle size ranges between 1-100 nm. It is extensively utilized in drug delivery and various other sectors, such as the pharmaceutical, food, and dairy industries. The nanocarrier systems, including solid lipid nanoparticles, micelles, liposomes, and other encapsulated compounds, have improved stability, solubility, bioavailability, and quality. Nanocarriers offer therapeutic effectiveness with low toxicity because of their biocompatibility and ability to cross body barriers. Various analytical techniques, such as chromatography and spectroscopy, are crucial in qualitative and quantitative analysis of nanocarrier-based formulations. Molecular identification and drug content determination require chromatographic techniques, particularly HPLC. Spectroscopic techniques such as LC-MS, NMR, GC-MS, CE-MS, Raman, and IR are used to analyze the interaction and molecular structure of the sample. Nanocarriers have several benefits but face various challenges like stability, drug loading, regulatory standards, and biocompatibility. Future surface engineering and nanocarrier design advancements could improve targeted drug delivery and sustained diagnostic applications, significantly impacting healthcare.

Rx for Legal Troubles: CEO Medical Degree and Corporate Litigation

ABSTRACTResearch Question/IssueThis study examines the relationship between CEOs' medical degrees (MDs) and corporate litigations targeting US pharmaceutical firms.Research Findings/InsightsCEOs with a medical background are significantly more susceptible to securities class actions, while facing fewer patent lawsuits. The results indicate that the lack of management skills among MD CEOs comes at the cost of firm value. After lawsuit announcements, companies led by MD CEOs experience a significantly negative effect on their stock prices. Markets show no tolerance for failures by MD CEOs, as evidenced by the impact of clinical trial disappointments.Theoretical/Academic ImplicationsThe findings contribute to our understanding of the impact of CEOs' medical backgrounds on corporate litigation outcomes. The results suggest that when examining how a CEO's qualifications affect legal issues and the value of a company, we should consider the unique context of having an MD.Practitioner/Policy ImplicationsPractically, the study implies that firms should carefully consider the balance of managerial and medical expertise in CEO appointments, recognizing the potential legal and financial consequences. Policymakers might see it as beneficial to encourage a mix of different skills among top executives. This could make pharmaceutical companies more resilient in the face of legal issues, which, in turn, helps maintain confidence among investors.

Revolutionizing Patient Safety: Machine Learning and AI for the Early Detection of Adverse Drug Reactions and Drug-Induced Toxicity

Adverse drug reactions and drug-induced toxicity provide significant issues in drug research, jeopardizing patient safety and driving up healthcare costs. Toxicity has a greater potential impact than infectious diseases since it is less visible. Early diagnosis of these difficulties is critical to determining a drug's safety and viability profile. The combination of machine learning and artificial intelligence has marked a watershed moment in the identification of early adverse drug reactions and toxicity. These computational approaches enable rapid, extensive, and precise prediction of likely adverse drug reactions and toxicity even before practical drug manufacture, preclinical testing, and clinical trials. This paradigm change strives to create more efficient and safe drugs, lowering the likelihood of drug withdrawal. This comprehensive review investigates the critical role of machine learning and artificial intelligence in quickly detecting adverse drug reactions and toxicity, including approaches from data mining to deep learning. It lists essential databases, modelling techniques, and software that may be used to model and predict a wide range of toxicities and adverse drug reactions. This review provides a comprehensive overview, outlining recent developments and projecting future opportunities in machine learning and artificial intelligence-driven rapid identification of adverse drug reactions and drug-induced toxicity. It highlights the capabilities of these technologies and their enormous potential to improve patient safety and revolutionize medication discovery.

The Influence Mechanism of Cultural Fit on the Image of Time-Honored Brands: Based on the Perspective of Brand Extension

ABSTRACT International competition and the continual emergence of new brands pose significant challenges to time-honored brands, prompting many of these established brands to adopt brand extension strategies as a means of reshaping and revitalizing their brand image. Based on the theory of brand legitimacy, this study constructs a research model of cultural fit – brand legitimacy – brand image and proposes pop culture involvement as a moderating variable. Two Chinese time-honored brands in the pharmaceutical industry, Tongrentang and Pientzehuang, were selected as the experiment scenarios. The study finds that: in the process of brand extension, cultural fit plays a positive role in influencing the brand image of the time-honored brands; brand legitimacy plays a mediation role between cultural fit and brand image; pop culture involvement plays a negative moderating role between cultural fit and brand legitimacy. Applications have also been mentioned in the study.

Cutting-Edge Applications of Cellulose-Based Membranes in Drug and Organic Contaminant Removal: Recent Advances and Innovations

The increasing environmental challenges caused by pharmaceutical waste, especially antibiotics and contaminants, necessitate sustainable solutions. Cellulose-based membranes are considered advanced tools and show great potential as effective materials for the removal of drugs and organic contaminants. This review introduces an environmentally friendly composite membrane for the elimination of antibiotics and dye contaminants from water and food, without the use of toxic additives. The potential of cellulose-based membranes in reducing the impact on water quality and promoting environmental sustainability is emphasized. Additionally, the benefits of using biobased cellulose membranes in membrane biological reactors for the removal of antibiotics from pharmaceutical waste and milk are explored, presenting an innovative approach to achieving a circular economy. This review provides recent and comprehensive insights into membrane bioreactor technology, making it a valuable resource for researchers seeking efficient methods to break down antibiotics in industrial wastewater, particularly in the pharmaceutical and dairy industries.

Interaction Between Heavy Metals Posed Chemical Stress and Essential Oil Production of Medicinal Plants.

Plants exposed to abiotic stressors show diverse physiological, biochemical, and molecular responses. Biosynthesis of plant secondary metabolites-including essential oils-is a vital plant defense mechanism. As these bioactive compounds are widely used in the pharmaceutical, cosmetic and food industries, it is essential to understand how their production is affected in various environments. While interaction between specific abiotic stressors such as salt stress has been widely studied, relatively less information is available on how essential oil production is affected by toxic contaminants. Present review intends to give an insight into the possible interaction between chemical stress and essential oil production, with special regard to soil and air pollution. Available studies clearly demonstrate that heavy metal induced stress does affect quantity and quality of EOs produced, however, pattern seems ambiguous as nature of effect depends on the plant taxon and on the EO. Considering mechanisms, genetic studies clearly prove that exposure to heavy metals influences the expression of genes being responsible for EO synthesis.

Optimization of Rotational Hydrodynamic Cavitation Reactor Geometry

A Rotary-Pulsation Apparatus (RPA), also known in the literature as a Rotational Hydrodynamic Cavitation Reactor (RHCR), is a device which typically consists of a rotating mechanism that generates pulsations or vibrations within a fluid. This can be achieved through various means such as mechanical agitation, pneumatic pulses, or hydraulic forces. It is widely used in food, chemical, pharmaceutical, and microbiological industries to improve the mixing of different fluids, dispersion, pasteurization, and sterilization. In the present paper, a CFD study was conducted to develop and optimize the geometry of the RPA’s rotor and stator to induce cavitation in the fluid flow. The effect of cavitation has the potential to improve dispersion and emulsion properties and to significantly reduce operation pressure, in comparison to conventional mixing systems.

Environmental impacts of drug products: The effect of the selection of production sites in the supply chain

The environmental impact of drug products is largely determined by activities beyond the direct control of pharmaceutical companies, such as outsourced production of pharmaceutical building blocks. Therefore, this study evaluates the environmental impacts of a prostate cancer drug packaged in one blister (declared unit), thereby analysing the whole value chain to gain insight into 1) the main contributors to the impact of drug product production and 2) the effect of the geographical location of production of solvents and pharmaceuticals. The carbon and resource footprints of the entire life cycle of the drug product are determined, using the IPCC GWP 100 and the Cumulative Exergy Extraction from the Natural Environment methods, respectively. Unlike many other studies, the impacts of building blocks, called intermediate pharmaceutical ingredients (IPIs), are modelled based on primary data, literature and similar processes. The carbon footprint per declared unit equals 34 kg CO2-eq, of which IPIs and active pharmaceutical ingredient (API) production account for 96 %. The resource footprint is 647 MJex/declared unit, with IPI and API production accounting for 93 %. The main impact contributors of these processes are solvents and electricity consumption. Four alternative scenarios for IPI and API production are developed to evaluate the geographical influence of different production locations of solvents and pharmaceuticals between Europe and China. European production of solvents and pharmaceuticals appears to have the lowest carbon and resource footprint. In contrast, Chinese production of solvents and pharmaceuticals increases the carbon footprint by 49 %, while the resource footprint increases by only 4 %, although the natural resource consumption shifts from abiotic renewable resources and nuclear energy to fossil fuels. The high contribution of IPI production and the influence of geography of the supply chain highlight the need for accurate data from external suppliers to fairly estimate the environmental footprint of drug products.

Structure Analysis and Forecast of Traditional Chinese Medicine (TCM) Exports to Australia Under the Perspective of Product Segmentation

Traditional Chinese medicine (TCM), as a precious treasure of China has played an indispensable role in combating the COVID-19 epidemic, and receiving widespread attention and high regard. The Chinese pharmaceutical industry is gradually on the Road of Revival. However, there are still many bottlenecks restricting internationalization of TCM. How to specifically expand the international market, optimize product structure, and enhance the competitiveness of TCM exports are key and difficult issues. In light of this, this article selects "Australia" as a typical region with a solid foundation for the development of TCM, and innovatively classifies TCM products into four major categories based on its market access policies. By applying STATA to construct an ARIMA model, this study analyzes and forecasts the total export volume of TCM to Australia, the export structure of each category, and the export value for the Q3 2024-Q2 2026 based on data from 2016 to Q2 2024. The results reveal that there is significant potential in the Australian market for the export of TCM. However, the export structure is heavily skewed towards primary products, with the growth rate of high-value-added products being relatively slow. Consequently, it is recommended to increase investment in the research and development of TCM, enhance consumer education to address cultural differences, promote the export of high-value-added products, strengthen the docking of international standards and export certification of products, reinforce brand building and bolster government guidance and talent cultivation to enhance the international competitiveness of the TCM.

Analysing the Capital Structure of Indian Entertainment and Pharmaceutical Industry: A Comparative Study

This research work has been done through the various analysis regarding the capital structure of different industries. The work has been done to know the different capital structure mix of Entertainment and Pharmaceutical industry of India. Where to know the Capital structure impact on the profitability of different companies along with Covid 19 period. I also had been used the statistical analysis for comparison of both the industries which is R Software programme. The panel data models had been analysed in this research with Fixed effect method of Least squared Dummy Variable [LSDV] model.

Revolutionizing Pharmacy Benefit Management: Cost-Reduction through Artificial Intelligence and Data Analytics in Healthcare

Pharmacy Benefit Managers (PBMs) are third party companies that function as intermediaries between insurance providers and pharmaceutical manufacturers. PBMs create formularies, negotiate rebates (discounts paid by a drug manufacturer to a PBM) with manufacturers, process claims, create pharmacy networks, review drug utilization, and occasionally manage mail-order specialty pharmacies. [1] Pharmacy benefit management (PBM) is important for keeping prescription drug costs under control. But the problem is that drug prices keep going up, which makes things tough for the healthcare industry. In this article, we look at how fancy technology like artificial intelligence (AI) and data analysis can help PBM find new ways to save money. By using advanced technology to study a large amount of information, PBMs can find patterns and make educated guesses about how to best use medications. Artificial intelligence makes this even more advanced by helping to quickly find and stop fraud, personalize medication plans, and predict costs more accurately. Remember this: AI and data analytics are being used to make pharmacy benefit programs work better. This helps save money and makes things better for patients. We look at how machine learning models can predict patient adherence, how natural language processing (NLP) can improve medication reviews, and how blockchain technology can keep supply chains transparent and secure. Real-world examples show how these technologies are already making a difference, such as cutting down on administrative work, reducing drug waste, and getting the most out of drug utilization. As more healthcare systems start using these advanced tools, it’s becoming clear that continual innovation and the inclusion of AI and data-driven methods are essential. This article highlights the importance of staying updated with the ever-changing ways of controlling prescription drug expenses by using new technology. For pharmacy benefit managers (PBMs) focused on offering the best value and working effectively despite increasing healthcare costs, adopting these advancements is not just a good choice, it's necessary.

Pectin-based encapsulation systems for the protection of beneficial bacterial species and impact on intestinal barrier function in vitro

Pectin is a complex polysaccharide important to the pharmaceutical and food industry, and due to its versatility, cheapness, and notable health benefits, it is proposed to be investigated as an encapsulation material to protect sensitive food components such as living bacteria during their passage through the gastrointestinal tract. The main objective of this study was to evaluate both, the ability of pectin-based beads to maintain the viability and functionality of L. plantarum WCFS1 and the protective effect on intestinal epithelial barrier disruption in vitro. Pectin isolated from lemon with two degrees of methylation (DM18 and DM88) was used to form microbeads with either alginate or chitosan, producing four bead types, which were alginate/pectin DM18 (AlgDM18), alginate/pectin DM88 (AlgDM88), chitosan/pectin DM18 (ChitoDM18), and chitosan/pectin DM88 (ChitoDM88).The beads were loaded with L. plantarum, and it was demonstrated that all pectin-based beads could preserve the viability of L. plantarum after encapsulation. While some differences in metabolism was observed, the alginate-pectin beads exhibited higher activity and loading capacity. Then these beads were tested on intestinal epithelial cells to assess their protective impact in the presence of a barrier disruptor A23187. The effect on gut barrier function demonstrates that the composition of the microbeads significantly affected their protective effects. Empty ChitoDM88 beads demonstrated protective effects by delaying barrier disruption and modulating the release of gut epithelial cell-specific cytokines. They increased the production of CCL20 while reducing levels of IL-8 and IL-13, which are markers of inflammation.L. plantarum WCFS1-loaded Chitosan DM88-pectin microbeads provided the strongest protection. These beads not only delayed disruption of the gut epithelial barrier but also increased epithelial barrier function before and after treatment of the monolayer with the A23187 disruptor. Additionally, the loaded ChitoDM88 beads upregulated key genes associated with the tight junction integrity of the intestinal epithelium, including ZO-1, Occludin, and Claudin-1, further supporting their protective role. The immune response was also modulated by the loaded ChitoDM88 beads, as they increased CCL20 production and reduced IL-8 levels, highlighting a bead-type-dependent impact on epithelial immune signaling.This study demonstrates that pectin-based microbeads can preserve the viability and functionality of encapsulated L. plantarum, protecting against gut barrier impairment. The results highlight pectin's potential as a promising polymer for probiotic delivery, with encapsulation effectiveness depending on the pectin's methylation degree and the stabilizing agent used.

Exploring Fish Processing By-Products as an Alternative Source of Bioactive Peptides: A Review on Extraction and Food Applications

Abstract Purpose of Review This review explores non-thermal-based extraction techniques for obtaining bioactive peptides from fish processing by-products. It emphasizes the potential of these peptides as alternatives in the development of functional foods. With a focus on preserving bioactivity, the review aims to explore the utilization of fish peptides in food applications. Recent Findings Recent research highlights the potential of bioactive peptides in the food, pharmaceutical, and cosmetic industries. Fish processing by-products are valuable sources of these peptides. Non-thermal technologies preserve their bioactivity, while encapsulation techniques further enhance peptide protection and efficacy in industrial applications. Summary This review highlights fish processing by-products as a source of bioactive peptides, with non-thermal extraction techniques preserving their bioactivity. It emphasizes their promising bioactivities for industrial use and the importance of encapsulation techniques in maintaining bioactivity. It provides comprehensive insights into their extraction, bioavailability, safety considerations, and food applications. Graphical Abstract